CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 53 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,097 | +96.7% | 34,189 | +80.1% | 0.00% | – |
| Q2 2023 | $49,358 | +42.9% | 18,984 | 0.0% | 0.00% | – |
| Q1 2023 | $34,551 | +40.5% | 18,984 | +27.3% | 0.00% | – |
| Q4 2022 | $24,597 | -1.6% | 14,907 | +13.1% | 0.00% | – |
| Q3 2022 | $25,000 | -35.9% | 13,175 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | -92.5% | 13,175 | -90.5% | 0.00% | – |
| Q1 2022 | $521,000 | -36.7% | 138,244 | +90.9% | 0.00% | – |
| Q4 2021 | $823,000 | -35.9% | 72,425 | -1.0% | 0.00% | – |
| Q3 2021 | $1,284,000 | – | 73,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $4,476,421 | 8.93% |
| Novo Holdings A/S | 3,940,413 | $112,892,832 | 7.45% |
| BML Capital Management, LLC | 3,146,296 | $5,726,259 | 4.95% |
| Newtyn Management, LLC | 952,947 | $1,734,364 | 0.34% |
| Aldebaran Capital, LLC | 151,239 | $275,255 | 0.28% |
| Avidity Partners Management LP | 1,764,100 | $3,210,662 | 0.11% |
| Marquette Asset Management, LLC | 67,990 | $123,742 | 0.03% |
| TANG CAPITAL MANAGEMENT LLC | 100,000 | $182,000 | 0.03% |
| RBF Capital, LLC | 117,295 | $213,477 | 0.02% |
| CAAS CAPITAL MANAGEMENT LP | 150,406 | $273,739 | 0.02% |